UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

Annals of oncology, 2021-06, Vol.32 (6), p.746-756

2021

Volltextzugriff (PDF)

Metastatic pancreatic cancer: Characteristics of long-term survivors

Annals of oncology, 2019-07, Vol.30, p.iv73-iv73

2019

Volltextzugriff (PDF)

Probabilistic assessment of footbridge response to single walkers

Archive of applied mechanics (1991), 2022, Vol.92 (6), p.1913-1927

2022

Volltextzugriff (PDF)

Correction of historical records to improve the reliability of design wind speeds

Engineering structures, 2022-08, Vol.265, p.114473, Article 114473

2022

Volltextzugriff (PDF)

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031

Annals of oncology, 2011-02, Vol.22 (2), p.348-354

2011

Volltextzugriff (PDF)

PANOVA-3: A phase 3 study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma (LAPC)

Annals of oncology, 2019-07, Vol.30, p.iv71-iv71

2019

Volltextzugriff (PDF)

SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

Annals of oncology, 2019-07, Vol.30, p.iv16-iv16

2019

Volltextzugriff (PDF)

Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

Annals of oncology, 2018-06, Vol.29, p.v43-v43

2018

Volltextzugriff (PDF)

P-180Health-related quality of life in patients with metastatic pancreatic cancer

Annals of oncology, 2016-06, Vol.27 (suppl_2), p.ii53-ii53

2016

Volltextzugriff (PDF)

P-266Metastatic pancreatic cancer: Characteristics of long-term survivors

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

Codifiable probability-based model for footbridges response to random walkers

Journal of physics. Conference series, 2024-06, Vol.2647 (12), p.122011

2024

Volltextzugriff (PDF)

Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

The American journal of surgery, 2000-05, Vol.179 (5), p.367-371

2000

Volltextzugriff (PDF)

P-120 Front-line treatment of locally advanced pancreatic adenocarcinoma with tumour treating fields concomitant with gemcitabine and nab-paclitaxel: The phase 3 PANOVA-3 study

Annals of oncology, 2022-06, Vol.33, p.S292

2022

Volltextzugriff (PDF)

PG-SGA scores in Pancreatic Cancer (PC): Improvement in Results under RD Supervision

Journal of the Academy of Nutrition and Dietetics, 2019-09, Vol.119 (9), p.A13-A13

2019

Volltextzugriff (PDF)

The Climatic Action Uncertainty Chain

Engineering structures, 2024-02, Vol.301, p.117357, Article 117357

2024

Volltextzugriff (PDF)

STABLE: an innovative device for three-part maxillary osteotomy

Minerva Dental and Oral Science, 2018-12, Vol.62 (4 Suppl 1)

2018

Volltextzugriff (PDF)

P-260PANOVA-3: A phase 3 study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma (LAPC)

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

Effect of Thermosetting Gel with Doxycycline Hyclate 3% + Ketorolac Tromethamine 0.5% on Postoperative Discomfort after Third Molar Surgery: A Prospective Randomized Study

European journal of inflammation, 2014-01, Vol.12 (1), p.203-208

2014

Volltextzugriff (PDF)

Effect of Thermosetting Gel with Doxycycline Hyclate 3% on Postoperative Discomfort after Third Molar Surgery: A Prospective Study

European journal of inflammation, 2013-05, Vol.11 (2), p.553-558

2013

Volltextzugriff (PDF)

P-059SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

Annals of oncology, 2019-07, Vol.30 (Supplement_4)

2019

Volltextzugriff (PDF)

PCN259 USING LONGITUDINAL PATIENT LEVEL DATA TO ASSESS THE VALUE OF NEW PANCREATIC CANCER TREATMENTS ON TOTAL HEALTH SPENDING

Value in health, 2020-05, Vol.23, p.S68-S69

2020

Volltextzugriff (PDF)

719PPhase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

Annals of oncology, 2019-10, Vol.30, p.v275

2019

Volltextzugriff (PDF)

719P - Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

Annals of oncology, 2019-10, Vol.30, p.v275-v275

2019

Volltextzugriff (PDF)

P-180 Health-related quality of life in patients with metastatic pancreatic cancer

Annals of oncology, 2016-06, Vol.27, p.ii53

2016

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(136)
Mit Volltextzugriff
(139)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(68)
Life Sciences & Biomedicine
(51)
Humans
(50)
Male
(43)
Female
(37)
Middle Aged
(32)
Adult
(30)
Aged
(28)
Biological And Medical Sciences
(23)
Medical Sciences
(22)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Oncology
(16)
Surgery
(14)
Neurosciences & Neurology
(11)
Physics
(11)
Technology
(11)
Animals
(10)
Clinical Neurology
(10)
Physical Sciences
(10)
Urology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trial

Metastatic pancreatic cancer: Characteristics of long-term survivors

Probabilistic assessment of footbridge response to single walkers

Correction of historical records to improve the reliability of design wind speeds

Multicenter phase II trial of adjuvant therapy for resected pancreatic cancer using cisplatin, 5-fluorouracil, and interferon-alfa-2b–based chemoradiation: ACOSOG Trial Z05031

PANOVA-3: A phase 3 study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma (LAPC)

SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

Open-label, multicenter, single-arm study of FABLOx (metronomic 5-fluorouracil plus nab-paclitaxel, bevacizumab, leucovorin, and oxaliplatin) in patients with metastatic pancreatic cancer: Phase I results

P-180Health-related quality of life in patients with metastatic pancreatic cancer

P-266Metastatic pancreatic cancer: Characteristics of long-term survivors

Codifiable probability-based model for footbridges response to random walkers

Interferon-based adjuvant chemoradiation therapy improves survival after pancreaticoduodenectomy for pancreatic adenocarcinoma

P-120 Front-line treatment of locally advanced pancreatic adenocarcinoma with tumour treating fields concomitant with gemcitabine and nab-paclitaxel: The phase 3 PANOVA-3 study

PG-SGA scores in Pancreatic Cancer (PC): Improvement in Results under RD Supervision

The Climatic Action Uncertainty Chain

STABLE: an innovative device for three-part maxillary osteotomy

P-260PANOVA-3: A phase 3 study of tumor treating fields with nab-paclitaxel and gemcitabine for front-line treatment of locally advanced pancreatic adenocarcinoma (LAPC)

Effect of Thermosetting Gel with Doxycycline Hyclate 3% + Ketorolac Tromethamine 0.5% on Postoperative Discomfort after Third Molar Surgery: A Prospective Randomized Study

Effect of Thermosetting Gel with Doxycycline Hyclate 3% on Postoperative Discomfort after Third Molar Surgery: A Prospective Study

P-059SM-88 therapy in high-risk poor prognosis pancreatic cancer (PDAC)

PCN259 USING LONGITUDINAL PATIENT LEVEL DATA TO ASSESS THE VALUE OF NEW PANCREATIC CANCER TREATMENTS ON TOTAL HEALTH SPENDING

719PPhase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

719P - Phase II monotherapy efficacy of cancer metabolism targeting SM-88 in heavily pre-treated PDAC patients

P-180 Health-related quality of life in patients with metastatic pancreatic cancer

Suchergebnisse filtern